Phase I clinical trial with a hexavalent PorA containing meningococcal outer membrane vesicle vaccine

By Peeters C.C.A.M.   Rumke H.C.   Sundermann L.C.   van der Voort E.M.R.   Meulenbelt J.   Schuller M.   Kuipers A.J.   van der Ley P.   Poolman J.T.  

Vaccine, Vol. 14, Iss. 10, 1996-07 ,pp. : 1009-1015

Elsevier

Access to resources Recommend Favorite

Immunogenicity studies with a genetically engineered hexavalent PorA and a wild-type meningococcal group B outer membrane vesicle vaccine in infant cynomolgus monkeys

By Rouppe van der Voort E.   Schuller M.   Holst J.   de Vries P.   van der Ley P.   van den Dobbelsteen G.   Poolman J.  

Vaccine, Vol. 18, Iss. 14, 2000-02 ,pp. : 1334-1343

Elsevier

Access to resources Recommend Favorite

Immunogenicity and reactogenicity in UK infants of a novel meningococcal vesicle vaccine containing multiple class 1 (PorA) outer membrane proteins

By Cartwright K.   Morris R.   Rumke H.   Fox A.   Ray Borrow   Begg N.   Richmond P.   Poolman J.  

Vaccine, Vol. 17, Iss. 20, 1999-06 ,pp. : 2612-2619

Elsevier

Access to resources Recommend Favorite

Comparison of PorA VR types and porA promoter sequence from Neisseria meningitidis B isolated from non-immunised children and vaccine failures immunised with a serogroup B outer membrane protein vaccine

By Gorla M.C.O.   Lemos A.P.S.   Sacchi C.T.   de Moraes J.C.   Milagres L.G.  

Vaccine, Vol. 21, Iss. 21, 2003-06 ,pp. : 2871-2876

Elsevier

Access to resources Recommend Favorite

Construction of Neisseria meningitidis strains carrying multiple chromosomal copies of the porA gene for use in the production of a multivalent outer membrane vesicle vaccine

By van der Ley P.   van der Biezen J.   Poolman J.T.  

Vaccine, Vol. 13, Iss. 4, 1995-01 ,pp. : 401-407

Elsevier

Access to resources Recommend Favorite